✦ LIBER ✦

KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer

✍ Scribed by Spindler, K G; Appelt, A L; Pallisgaard, N; Andersen, R F; Jakobsen, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MC13-0026 KRAS mutated plasma DNA as pre

✍ Spindler, K.; Appelt, L.A.; Pallisgaard, N.; Andersen, F.R.; Jakobsen, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Quantitative Cell-Free DNA, KRAS, and BR

✍ Spindler, K.-L. G.; Pallisgaard, N.; Vogelius, I.; Jakobsen, A. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

6105 POSTER Phase II Trial of Temsirolim

✍ Spindler, K.G.; Sorensen, M.; Pallisgaard, N.; Andersen, R.F.; Lassen, U.; Havel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Changes in mutational status during thir

✍ Spindler, Karen-Lise Garm; Pallisgaard, Niels; Andersen, Rikke Fredslund; Jakobs 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB

6113 BRAF V600E mutation and Amphireguli

✍ Cremolini, C.; Loupakis, F.; Perrone, G.; Ruzzo, A.; Rulli, E.; Bencardino, K.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

3014 (Presidential session, Tue 25 Sep 1

✍ D. Freeman; T. Juan; N.J. Meropol; J.R. Hecht; J. Berlin; E. van Cutsem; M. Rein 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB